Sfoglia per Autore
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis
2018 Paoletti, Federico Paolini; Di Gregorio, Maria; Calabresi, Paolo; Parnetti, Lucilla
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort
2018 Eusebi, Paolo; Romoli, Michele; Paoletti, Federico Paolini; Tambasco, Nicola; Calabresi, Paolo; Parnetti, Lucilla
Levodopa-responsive breathing discomfort in Parkinson’s disease patients
2018 Tambasco, Nicola; Murgia, Nicola; Nigro, Pasquale; PAOLINI PAOLETTI, Federico; Romoli, Michele; Brahimi, Elona; Filidei, Marta; Simoni, Simone; Muzi, Giacomo; Calabresi, Paolo
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study
2019 Cardaioli, G.; Ripandelli, F.; Paolini Paoletti, F.; Nigro, P.; Simoni, S.; Brahimi, E.; Romoli, M.; Filidei, M.; Eusebi, P.; Calabresi, P.; Tambasco, N.
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease
2019 Tambasco, N.; Paolini Paoletti, F.; Chiappiniello, A.; Lisetti, V.; Nigro, P.; Eusebi, P.; Chiarini, P.; Romoli, M.; Brahimi, E.; Simoni, S.; Filidei, M.; Floridi, P.; Tarducci, R.; Parnetti, L.; Calabresi, P.
Levodopa treatment in Parkinson's disease: earlier or later?
2019 Paolini Paoletti, Federico; Tambasco, Nicola; Parnetti, Lucilla
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
2020 Gaetani, L.; Paolini Paoletti, F.; Bellomo, G.; Mancini, A.; Simoni, S.; Di Filippo, M.; Parnetti, L.
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
2020 Bellomo, Giovanni; Paolini Paoletti, Federico; Chipi, Elena; Petricciuolo, Maya; Simoni, Simone; Tambasco, Nicola; Parnetti, Lucilla
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
2020 Farotti, L.; Paolini Paoletti, F.; Simoni, S.; Parnetti, L.
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ?
2020 Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L.
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.
2020 Paolini Paoletti, F; Gaetani, L; Parnetti, L
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation
2020 Simoni, Simone; Paoletti, Federico Paolini; Eusebi, Paolo; Cappelletti, Giulia; Filidei, Marta; Brahimi, Elona; Nigro, Pasquale; Santangelo, Valerio; Parnetti, Lucilla; Calabresi, Paolo; Tambasco, Nicola
Molecular profiling in Parkinsonian syndromes: CSF biomarkers
2020 Paolini Paoletti, F.; Gaetani, L.; Parnetti, L.
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study
2021 Nigro, P.; Chiappiniello, A.; Simoni, S.; Paolini Paoletti, F.; Cappelletti, G.; Chiarini, P.; Filidei, M.; Eusebi, P.; Guercini, G.; Santangelo, V.; Tarducci, R.; Calabresi, P.; Parnetti, L.; Tambasco, N.
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease
2021 Nuzzo, Tommaso; Mancini, Andrea; Miroballo, Mattia; Casamassa, Alessia; Di Maio, Anna; Donati, Giorgia; Sansone, Giulia; Gaetani, Lorenzo; PAOLINI PAOLETTI, Federico; Isidori, Andrea; Calabresi, Paolo; Errico, Francesco; Parnetti, Lucilla; Usiello, Alessandro
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders
2021 Bellomo, Giovanni; Indaco, Antonio; Chiasserini, Davide; Maderna, Emanuela; Paolini Paoletti, Federico; Gaetani, Lorenzo; Paciotti, Silvia; Petricciuolo, Maya; Tagliavini, Fabrizio; Giaccone, Giorgio; Parnetti, Lucilla; Di Fede, Giuseppe
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease
2022 Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus
Blood biomarkers may distinguish among dementia disorders
2022 Parnetti, Lucilla; Paolini Paoletti, Federico; Gaetani, Lorenzo
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation
2022 Wojdała, Anna Lidia; Chiasserini, Davide; Bellomo, Giovanni; Paciotti, Silvia; Gaetani, Lorenzo; Paoletti, Federico Paolini; Parnetti, Lucilla
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward
2022 Bellomo, Giovanni; De Luca, Chiara Maria Giulia; Paoletti, Federico Paolini; Gaetani, Lorenzo; Moda, Fabio; Parnetti, Lucilla
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis | 2018 | Paoletti, Federico Paolini; Di Gregorio, Maria; Calabresi, Paolo; Parnetti, Lucilla | |
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort | 2018 | Eusebi, Paolo; Romoli, Michele; Paoletti, Federico Paolini; Tambasco, Nicola; Calabresi, Paolo; Parnetti, Lucilla | |
Levodopa-responsive breathing discomfort in Parkinson’s disease patients | 2018 | Tambasco, Nicola; Murgia, Nicola; Nigro, Pasquale; PAOLINI PAOLETTI, Federico; Romoli, Michele; Brahimi, Elona; Filidei, Marta; Simoni, Simone; Muzi, Giacomo; Calabresi, Paolo | |
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study | 2019 | Cardaioli, G.; Ripandelli, F.; Paolini Paoletti, F.; Nigro, P.; Simoni, S.; Brahimi, E.; Romoli, M.; Filidei, M.; Eusebi, P.; Calabresi, P.; Tambasco, N. | |
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease | 2019 | Tambasco, N.; Paolini Paoletti, F.; Chiappiniello, A.; Lisetti, V.; Nigro, P.; Eusebi, P.; Chiarini, P.; Romoli, M.; Brahimi, E.; Simoni, S.; Filidei, M.; Floridi, P.; Tarducci, R.; Parnetti, L.; Calabresi, P. | |
Levodopa treatment in Parkinson's disease: earlier or later? | 2019 | Paolini Paoletti, Federico; Tambasco, Nicola; Parnetti, Lucilla | |
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment | 2020 | Gaetani, L.; Paolini Paoletti, F.; Bellomo, G.; Mancini, A.; Simoni, S.; Di Filippo, M.; Parnetti, L. | |
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies | 2020 | Bellomo, Giovanni; Paolini Paoletti, Federico; Chipi, Elena; Petricciuolo, Maya; Simoni, Simone; Tambasco, Nicola; Parnetti, Lucilla | |
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers | 2020 | Farotti, L.; Paolini Paoletti, F.; Simoni, S.; Parnetti, L. | |
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? | 2020 | Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L. | |
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. | 2020 | Paolini Paoletti, F; Gaetani, L; Parnetti, L | |
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation | 2020 | Simoni, Simone; Paoletti, Federico Paolini; Eusebi, Paolo; Cappelletti, Giulia; Filidei, Marta; Brahimi, Elona; Nigro, Pasquale; Santangelo, Valerio; Parnetti, Lucilla; Calabresi, Paolo; Tambasco, Nicola | |
Molecular profiling in Parkinsonian syndromes: CSF biomarkers | 2020 | Paolini Paoletti, F.; Gaetani, L.; Parnetti, L. | |
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study | 2021 | Nigro, P.; Chiappiniello, A.; Simoni, S.; Paolini Paoletti, F.; Cappelletti, G.; Chiarini, P.; Filidei, M.; Eusebi, P.; Guercini, G.; Santangelo, V.; Tarducci, R.; Calabresi, P.; Parnetti, L.; Tambasco, N. | |
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease | 2021 | Nuzzo, Tommaso; Mancini, Andrea; Miroballo, Mattia; Casamassa, Alessia; Di Maio, Anna; Donati, Giorgia; Sansone, Giulia; Gaetani, Lorenzo; PAOLINI PAOLETTI, Federico; Isidori, Andrea; Calabresi, Paolo; Errico, Francesco; Parnetti, Lucilla; Usiello, Alessandro | |
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders | 2021 | Bellomo, Giovanni; Indaco, Antonio; Chiasserini, Davide; Maderna, Emanuela; Paolini Paoletti, Federico; Gaetani, Lorenzo; Paciotti, Silvia; Petricciuolo, Maya; Tagliavini, Fabrizio; Giaccone, Giorgio; Parnetti, Lucilla; Di Fede, Giuseppe | |
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease | 2022 | Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus | |
Blood biomarkers may distinguish among dementia disorders | 2022 | Parnetti, Lucilla; Paolini Paoletti, Federico; Gaetani, Lorenzo | |
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation | 2022 | Wojdała, Anna Lidia; Chiasserini, Davide; Bellomo, Giovanni; Paciotti, Silvia; Gaetani, Lorenzo; Paoletti, Federico Paolini; Parnetti, Lucilla | |
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward | 2022 | Bellomo, Giovanni; De Luca, Chiara Maria Giulia; Paoletti, Federico Paolini; Gaetani, Lorenzo; Moda, Fabio; Parnetti, Lucilla |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile